Split History
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| CASI Stock Split History |
| Preferred Stock Newsletter |
| CASI Options Chain |
| Stock Message Boards |
CASI (CASI) has 1 split in our CASI split history database. The split for CASI took place on June 02, 2022. This was a 1 for 10 reverse split, meaning for each 10 shares of CASI owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as CASI conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the CASI split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CASI shares, starting with a $10,000 purchase of CASI, presented on a split-history-adjusted basis factoring in the complete CASI split history.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 05/17/2016 | |
| End date: | 02/25/2026 | |
| Start price/share: | $12.30 | |
| End price/share: | $0.21 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -98.29% | |
| Average Annual Total Return: | -34.03% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $170.83 | |
| Years: | 9.78 | |
 |
| About CASI |
| CASI Pharmaceuticals, Inc. is a biopharmaceutical company. Co. is focused on developing and commercializing therapeutics and pharmaceutical products in China, the U.S., and throughout the world. Co. is focused on acquiring, developing, and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. Its commercial product, EVOMELA, is an intravenous formulation of melphalan commercialized by Acrotech in the multiple myeloma treatment setting in the U.S.. Its pipeline products include CNCT19 (CD19 CAR-T), BI-1206 (anti- FcYRIIB antibody), CB-5339 (VCP/p97 inhibitor), CID-103 (Anti-CD38 Mab), Thiotepa, and Octreotide LAI. According to our CASI split history records, CASI has had 1 split. |
| CASI Split History Table | |
| Date | Ratio |
| 06/02/2022 | 1 for 10 |
| Healthcare Stock Splits |
| CASI is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
CATB Split History Also explore: CASI shares outstanding history
|
Free CASI Email Alerts:
